Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery: A Pilot, Multi-centre, Placebo-controlled Randomized Trial
Conditions: Chronic Iron Deficiency Anaemia; Cardiac Surgery Interventions: Drug: Monoferric Injectable Product; Other: 0.9% sodium chloride solution Sponsors: University Health Network, Toronto; Queen ' s University; Sunnybrook Health Sciences Centre; Heart and Stroke Foundation of Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients.
Conditions: Cardiac Surgery; High Risk Patients; Intensive Care Unit; Cardiopulmonary Bypass; Valve Surgeries Interventions: Drug: Long-chain n-3 fatty acids; Drug: Intravenous 0.9% Sodium Chloride Sponsors: GCP-Service International West GmbH; Charite University, Berlin, Germany; Wuerzburg University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Topical Anaesthesia in Cutaneous Head and Neck Surgery
Conditions: Pain, Acute; Head and Neck Cancer; Cutaneous Tumor Interventions: Drug: EMLA; Drug: Ethyl chloride; Drug: Aqueous cream BP Sponsors: University Hospital Waterford Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery.
Conditions: Surgical Complication Interventions: Drug: Tranexamic Acid 100 MG/ML; Drug: 0.9%sodium chloride Sponsors: St. Olavs Hospital; Smerud Medical Research International AS; Sykehuset Asker og Baerum; Oslo universitetssykehus HF; Sykehuset Telemark; Sykehuset Innlandet HF; Molde Hospital; Haukeland University Hospital; Haraldsplass Deaconess Hospital; Helse Stavanger HF; University Hospital of North Norway; Bod ΓΈ sykehus; Helsinki University Central Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion
Conditions: Lumbar Spondylolisthesis; Arthrosis; Spine Interventions: Drug: Caroxime sodium sulfonate; Drug: Desmopressin; Drug: 0.9% Sodium Chloride Injection Sponsors: Chengdu University of Traditional Chinese Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)
Conditions: Viral Pharyngitis Interventions: Drug: CPC mouthwash; Drug: Placebo Sponsors: Dentaid SL; Methodex Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
Conditions: Elective Cesarean Delivery Interventions: Drug: Calcium Gluconate 10%; Drug: sodium chloride 0.9% Sponsors: Rambam Health Care Campus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
Conditions: Metabolic Acidosis; CKD; Electrolyte and Fluid Balance Conditions Interventions: Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of potassium chloride; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of potassium gluconate; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of potassium bicarbonate; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of sodium chloride; Dietary Supplement: Dietary supplement consisting of 40 mmol/daily of sodium bicarbonate; Dietary Supplement: Placebo caps Sponsors: Erasmus Medical Center Not yet recruiting (...
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery
Conditions: Foot Injuries and Disorders; Ankle Injuries and Disorders Interventions: Drug: 0.9%sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty
Conditions: Hip Osteoarthritis; Hip Arthropathy; Hip Pain Chronic Interventions: Drug: 0.9%sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery
Conditions: Spinal Fusion; Spine Disease; Spinal Stenosis; Erector Spinae Plane Block Interventions: Drug: 0.9% Sodium Chloride Injection; Drug: Dexamethasone 4 Mg/mL Injectable Solution; Drug: Dexmedetomidine injection Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers
Conditions: Decompression Sickness Interventions: Drug: Sodium Chloride 0.9% Inj pre-exposure; Drug: Sodium Chloride 0.9% Inj post-exposure; Drug: Recombinant human plasma gelsolin pre-exposure; Drug: Recombinant human plasma gelsolin post-exposure; Other: Hyperbaric chamber Sponsors: BioAegis Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
OnabotulinumtoxinA for Trigeminal Neuralgia
Conditions: Trigeminal Neuralgia Interventions: Drug: OnabotulinumtoxinA 100 UNT [Botox]; Drug: Sodium Chloride 0.9% for Injection, Preservative Free Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Conditions: Heart Failure; Diuretic Resistance Interventions: Drug: Ammonium Chloride; Drug: Placebo Sponsors: Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: 3 ampoules of SHPL-49 Injection; Drug: 6 ampoules of SHPL-49 Injection; Drug: 0.9% Sodium Chloride Injection Sponsors: Shanghai Hutchison Pharmaceuticals Limited; Beijing Tiantan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
